The European VC (EUVC)
Interviews with Europe's top VCs exploring trends, fundraising, and firm-building strategies.
E720 | Henrietta Moon, Carbo Culture on Building Multi-Revenue Carbon Removal
In this episode, Henrietta Moon, founder and CEO of Carboculture, explains how her company uses high‑temperature biochar factories to simultaneously produce renewable energy, premium growing media, and permanently sequester carbon for centuries. She outlines a full‑stack business model that sells biochar to greenhouse growers, supplies heat and power to adjacent facilities, and monetizes carbon removal through emerging EU standards, while leveraging a mix of venture capital, public grants, and project financing. Moon highlights the recent EU carbon‑removal methodology as a game‑changing regulatory milestone that will likely set a global benchmark, and she stresses the resilience of her revenue streams despite a volatile climate‑funding environment. The discussion also touches on the broader need to amplify women‑led climate tech ventures and the importance of aligning climate solutions with essential sectors like food and energy.
E706 | Jo Slota-Newson & Marc Sabas, Almanac Ventures: Systemic Deep Tech for Industrial Decarbonisation
Almanac Ventures, founded by deep‑tech scientist Jo Slota‑Newson and finance‑focused Marc Sabas, invests seed‑stage deep‑tech solutions for industrial decarbonisation across Europe. They target technologies that improve performance, lower costs, and cut emissions in complex, capital‑intensive sectors that account for 75%...
E705 | Martin Schilling, Deep Tech Momentum: Why Europe’s Deep Tech Problem Isn’t Funding
In this episode, Martin Schilling, co‑founder of Deep Tech Momentum, explains that Europe’s deep‑tech challenge is not a lack of funding but a commercialization gap: large corporates aren’t buying or partnering with startups at scale. He highlights stark statistics—European firms...
E703 | Max Bray and Juliet Bailin, Kindred Capital VC: LP Conviction, $15B Funds & The Venture Barbell
In this episode Max Bray and Juliet Bailin of Kindred Capital discuss the current state of venture capital, focusing on LP conviction, the challenges of fundraising in a tough macro environment, and the emerging split between large, secure funds and...
The New European Sovereignty Stack: Energy, Minerals, Compute
The episode examines Europe’s modern sovereignty as an industrial and supply‑chain challenge, focusing on semiconductors, rare‑earth minerals, and energy infrastructure. Guests highlight Europe’s heavy reliance on imports, a thin venture‑capital ecosystem, and the need for coordinated capital to close the...
E695 | This Week in European Tech with Dan & Mads (Feat. Sam Marchant)
In this episode of Upside, Dan, Mads, and guest Sam Marchant dissect the surge of capital into enterprise AI, highlighting Anthropic’s $30 billion round and contrasting it with OpenAI’s shift toward consumer‑focused monetization. They explore the paradox of AI‑driven productivity, where...
E692 | Debbie Wosskow OBE, Chair of the UK’s Invest in Women Task Force: Mixed Teams, Better Returns, Real Incentives
In this episode, Andreas interviews Debbie Wosskow OBE, a serial founder and chair of the UK’s Invest in Women Task Force, about the shift from gender‑equity intentions to actual capital flows in venture. She explains how aligning incentives and power...
E690 | Sacha Michaud, Glovo: Scaling a Hyper-Competitive Marketplace (and Knowing when to Exit)
In this episode, former race‑horse jockey turned Glovo co‑founder Sacha Michaud walks through the operator playbook that powered Glovo’s rapid rise and disciplined exits. He explains how the company launched its MVP in 2.5 months, scaled internationally with a launch‑team...
E686 | Jan Hofmann, Viessmann Generations Group and Christian Hernandez, 2150: From Climate Hype to Industrial Reality
In this episode, host Andreas Munk Holm talks with Jan Hofmann of Viessmann Generations Group and Christian Hernandez, GP of 2150, about the current state of climate‑tech investing. They argue that hype has faded, leaving only robust business models and...
E680 | Oskar Hartmann, Accumulator: From Beast Mode to a New Angel Investing Model
In this episode, Andreas Munk Holm talks with Oskar Hartmann, a serial founder turned super‑angel, about his "beast mode" approach, burnout lessons, and the importance of product‑soul fit. Hartmann explains the new Accumulator model—a share‑pooling mechanism that gives founders and...
E679 | This Week in European Tech with Dan, Mads & Lomax
In this episode Dan Bowyer, Mads Jensen, and Lomax Ward dissect a range of power shifts across European tech, from OpenAI’s health‑focused ChatGPT and the FDA’s fast‑track AI medical device approvals to Meta’s acquisition of AI‑agent platform Manus and Nvidia’s...
E677 | Michael Brehm, Redstone: One Investment, 200 Ventures — The New Blueprint for European VC Access
In this episode, Michael Brehm of Redstone explains how the firm backs a single investment across 200 European ventures, creating a new model for VC access that spreads risk and capital efficiently. He discusses the rationale behind concentrating capital, the...
Stefan Roebel: Building Europe’s New Defense Tech Prime
In this episode, Stefan Roebel, co‑founder and CEO of ARX Robotics, discusses how his company evolved from makeshift decoy robots to NATO‑backed modular systems now operating in Ukraine, illustrating the need for Europe to overhaul its slow defence procurement and...
Matthew Wilson (Jack & Jill) & Peter Specht (Creandum): AI Recruiting Agents, a $20M Seed & the New GTM Playbook
In this episode, Matthew Wilson of Jack & Jill and investor Peter Specht discuss how AI-driven recruiting agents are reshaping a broken talent market, highlighting the founding insight that voice‑based agents can create a high‑signal two‑sided marketplace. They explain Jack’s...
Sergey Jakimov, LongeVC: Impacting Lives Through Longevity & Health Investing
In this episode, Sergey Jakimov, co‑founder of LongeVC, explains the firm’s $1.6 trillion longevity market thesis, its AI‑enhanced deal sourcing, and the strong track record of Fund I (over 3x MOIC with zero write‑offs). He walks through three flagship investments—Insilico Medicine, Turn...